Emerging care network Novo Integrated Sciences operates through Canadian and U.S. subsidiaries focused on multidisciplinary primary health care, offering a broad suite of services from physiotherapy and chiropractic care to concussion management and eldercare. This breadth creates cross-sell opportunities across related health services and potential integration with medical technology platforms for ongoing patient monitoring.

Low revenue, strong funding Current revenue is under one million dollars but the company has secured fifteen million dollars in funding. This suggests available capital for rapid customer acquisition, platform development, and strategic partnerships to scale services and expand geographic reach.

Tech-enabled care The company emphasizes extending patient oversight beyond facilities via medical technology platforms, indicating opportunities to partner with health tech providers for remote monitoring, tele-rehab, and data-driven outcomes, which can be leveraged to upsell integrated tech-enabled services to clinics and healthcare systems.

Strategic partnerships With a focus on integrated medical technology and rehabilitative science, there is potential to collaborate with medical device makers, rehabilitation product suppliers, and nutrition/dietary brands to offer bundled solutions across clinics, enabling co-marketing and referral-based sales channels.

Market positioning Operating in a competitive health sciences space with peers of varying sizes, Novo can differentiate by targeting mid-tier clinics and specialty centers seeking multidisciplinary care, offering scalable service lines and turnkey implementation of tech-enabled monitoring to accelerate adoption and revenue growth.